Citius Pharmaceuticals, Inc.·4

Oct 12, 4:15 PM ET

MCGRATH DENNIS M 4

4 · Citius Pharmaceuticals, Inc. · Filed Oct 12, 2023

Insider Transaction Report

Form 4
Period: 2023-10-10
Transactions
  • Award

    Options to Purchase Common Stock

    2023-10-10+75,00075,000 total
    Exercise: $0.70Exp: 2033-10-10Common Stock (75,000 underlying)
Holdings
  • Options to Purchase Common Stock

    Exercise: $1.42Exp: 2033-02-07Common Stock (75,000 underlying)
    75,000
Footnotes (2)
  • [F1]The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
  • [F2]The options were granted on February 7, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary